文献速递肿瘤 PET/CT神经核医学

使用[18F]FDG PET/MRI检测儿童和年轻成人癌症幸存者中大剂量甲氨蝶呤所致脑改变:一项先导研究

Detecting High-Dose Methotrexate-Induced Brain Changes in Pediatric and Young Adult Cancer Survivors Using [18F]FDG PET/MRI: A Pilot Study.
PubMed 文献 · J Nucl Med · 2024-06-03

这项前瞻性单中心先导研究纳入10例儿童和年轻成人癌症幸存者(肉瘤5例、淋巴瘤4例、白血病1例),在同一天进行脑[18F]FDG PET/MRI和2小时专家神经心理评估。结果显示前额叶皮质和扣带回的SUVmean与DKEFS-序列追踪z评分显著相关(分别为P=0.003和P=0.012),扣带回、海马和前额叶皮质的CBFmean与DKEFS-TM4显著相关(均P<0.001)。结论认为大剂量甲氨蝶呤所致脑损伤可表现为特定脑区葡萄糖代谢和血流降低,可用[18F]FDG PET/MRI检测。

要点

  • 前额叶皮质SUVmean与DKEFS-TM4 z评分显著相关(P=0.003),扣带回SUVmean亦相关(P=0.012)。
  • 扣带回、海马和前额叶皮质CBFmean均与DKEFS-TM4显著相关(均P<0.001)。
  • 海马CBFmean与负向WRAML-VIS z评分显著相关(P=0.003)。

核心结论

  • 大剂量甲氨蝶呤所致脑损伤可表现为特定脑区葡萄糖代谢和血流降低,可用[18F]FDG PET/MRI检测。
  • 前额叶皮质和扣带回的SUVmean及CBFmean可作为检测执行功能障碍的定量指标。
  • 海马CBFmean可能有助于监测记忆问题。

研究设计与样本

  • 前瞻性单中心先导研究,纳入10例儿童和年轻成人癌症幸存者,其中肉瘤5例、淋巴瘤4例、白血病1例。
  • 受试者在同一天接受专门脑[18F]FDG PET/MRI和2小时专家神经心理评估。
  • 神经心理评估包括韦氏智力简版第二版(智力功能)、Delis-Kaplan执行功能系统(DKEFS,执行功能)和广泛范围记忆与学习评估第二版(WRAML,言语和视觉记忆)。
  • 使用PMOD软件测量前额叶皮质、扣带回和海马3个皮质区域的SUVmean、皮质厚度、平均脑血流量(CBFmean)和平均表观扩散系数。
  • 对不同测量的标准化评分转换为z评分,对每个脑区、影像指标和测试评分拟合成对多变量回归模型(一个用于z评分<0,一个用于z评分>0),并使用异方差回归模型校正脑区间方差异质性和患者内聚类。

主要发现

  • 前额叶皮质SUVmean与DKEFS-序列追踪(DKEFS-TM4)z评分显著相关(P=0.003),扣带回SUVmean亦显著相关(P=0.012)。
  • 海马SUVmean与DKEFS-TM4 z评分无显著相关(P=0.111)。
  • 任何评估脑区的SUVmean与WRAML-视觉记忆(WRAML-VIS)z评分均无显著相关。
  • CBFmean与SUVmean呈正相关(r=0.56,P=0.01)。
  • 扣带回、海马和前额叶皮质的CBFmean与DKEFS-TM4显著相关(均P<0.001);海马CBFmean与负向WRAML-VIS z评分显著相关(P=0.003)。

关键数值与推荐

  • 前额叶皮质SUVmean与DKEFS-TM4 z评分相关P=0.003,扣带回SUVmean与DKEFS-TM4 z评分相关P=0.012。
  • 海马SUVmean与DKEFS-TM4 z评分相关P=0.111。
  • CBFmean与SUVmean正相关r=0.56,P=0.01。
  • 扣带回、海马和前额叶皮质CBFmean与DKEFS-TM4相关均P<0.001。
  • 海马CBFmean与负向WRAML-VIS z评分相关P=0.003。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Significant improvements in treatments for children with cancer have resulted in a growing population of childhood cancer survivors who may face long-term adverse outcomes. Here, we aimed to diagnose high-dose methotrexate-induced brain injury on [18F]FDG PET/MRI and correlate the results with cognitive impairment identified by neurocognitive testing in pediatric cancer survivors. Methods: In this prospective, single-center pilot study, 10 children and young adults with sarcoma (n = 5), lymphoma (n = 4), or leukemia (n = 1) underwent dedicated brain [18F]FDG PET/MRI and a 2-h expert neuropsychologic evaluation on the same day, including the Wechsler Abbreviated Scale of Intelligence, second edition, for intellectual functioning; Delis-Kaplan Executive Function System (DKEFS) for executive functioning; and Wide Range Assessment of Memory and Learning, second edition (WRAML), for verbal and visual memory. Using PMOD software, we measured the SUVmean, cortical thickness, mean cerebral blood flow (CBFmean), and mean apparent diffusion coefficient of 3 different cortical regions (prefrontal cortex, cingulate gyrus, and hippocampus) that are routinely involved during the above-specified neurocognitive testing. Standardized scores of different measures were converted to z scores. Pairs of multivariable regression models (one for z scores < 0 and one for z scores > 0) were fitted for each brain region, imaging measure, and test score. Heteroscedasticity regression models were used to account for heterogeneity in variances between brain regions and to adjust for clustering within patients. Results: The regression analysis showed a significant correlation between the SUVmean of the prefrontal cortex and cingulum and DKEFS-sequential tracking (DKEFS-TM4) z scores (P = 0.003 and P = 0.012, respectively). The SUVmean of the hippocampus did not correlate with DKEFS-TM4 z scores (P = 0.111). The SUVmean for any evaluated brain regions did not correlate significantly with WRAML-visual memory (WRAML-VIS) z scores. CBFmean showed a positive correlation with SUVmean (r = 0.56, P = 0.01). The CBFmean of the cingulum, hippocampus, and prefrontal cortex correlated significantly with DKEFS-TM4 (all P < 0.001). In addition, the hippocampal CBFmean correlated significantly with negative WRAML-VIS z scores (P = 0.003). Conclusion: High-dose methotrexate-induced brain injury can manifest as a reduction in glucose metabolism and blood flow in specific brain areas, which can be detected with [18F]FDG PET/MRI. The SUVmean and CBFmean of the prefrontal cortex and cingulum can serve as quantitative measures for detecting executive functioning problems. Hippocampal CBFmean could also be useful for monitoring memory problems.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Baratto L, Singh SB, Williams SE, et al. Detecting High-Dose Methotrexate-Induced Brain Changes in Pediatric and Young Adult Cancer Survivors Using [18F]FDG PET/MRI: A Pilot Study. J Nucl Med. 2024. PMID: 38575193. doi:10.2967/jnumed.123.266760

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。